The stock hit a new high of ₹1,095, appreciated 117% from its 52-week low of ₹504.30 touched on January 28, 2025.

Indian equity markets remain in a tight range in the weekly expiry session on Thursday. However, pockets of opportunity are emerging, with SEBI-registered analysts Kavita Agrawal and Vinay Taparia ...

Laurus Labs management said the fundamentals of the company's business remain strong, with sustained growth momentum in the Contract Development and Manufacturing Organization and Generic business.

Hyderabad: Laurus Bio, a subsidiary of Hyderabad-based biopharma player Laurus Labs Ltd, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital. Laurus Labs ...

The FDA, which issued India’s Laurus Synthesis a Form 483 in January, followed up the action with an "untitled letter" (PDF) that outlined the Indian drugmaker’s problems with its quality control unit ...

The Laurus is part of The Luxury Collection brand, under Marriott International. It is a new luxury hotel that was recently opened, and features interiors filled with Peranakan, colonial and tropical ...

When Dr Satyanarayana Chava started Laurus Labs in 2007, he invested nearly Rs 60 crore of his own money into it. His confidence in its success was neither bravado nor bluster, but defined by his ...

Revenue: INR1,570 crores, reflecting a 31% year-on-year growth. Gross Margin: 59%, an increase of more than 4% due to better product mix and process improvements. EBITDA: INR389 crores with a margin ...

Laurus Labs API segment is also well set to clock strong growth backed by the company’s increasing focus to diversify into new therapy areas - anti-diabetes and cardiology along with an eye to gain a ...

Laurus Labs has seen its consensus analyst price target edge up slightly from ₹815.86 to ₹821.93. This signals renewed confidence among market watchers. This shift comes as experts weigh in on the ...

PetroAlgae, a Melbourne, Fla., company, is a renewable energy miracle--at least in the stock market. The company, which aims to harvest oil from algae, started trading on the OTC Bulletin Board in ...